سامانه جستجوی جامع منابع دانشگاه علوم پزشکی جندی شاپور اهواز



عنوان مرجع : How does an anticholinergic agent added to an inhaled short-acting beta-agonist (SABA) compare with SABA alone for emergency management of asthma in adults?

ناشر : John Wiley & Sons, Ltd

DOI کد :

10.1002/cca.1826

سال انتشار : 2017

نوع : مرجع

لینک خروجی به مرجع

@incollection{1,
    doi = {10.1002/cca.1826},
    url = {http://dx.doi.org/10.1002/cca.1826},
    year = 2017,
    publisher = {John Wiley & Sons, Ltd},
    pages = {},
    author = {},
    title = {How does an anticholinergic agent added to an inhaled short-acting beta-agonist (SABA) compare with SABA alone for emergency management of asthma in adults?}
}
TY  - DATA
DO  - 10.1002/cca.1826
UR  - http://dx.doi.org/10.1002/cca.1826
TI  - How does an anticholinergic agent added to an inhaled short-acting beta-agonist (SABA) compare with SABA alone for emergency management of asthma in adults?
PY  - 2017
PB  - John Wiley & Sons, Ltd
SP  - 
AU  -
, T. (2017). How does an anticholinergic agent added to an inhaled short-acting beta-agonist (SABA) compare with SABA alone for emergency management of asthma in adults?. doi:10.1002/cca.1826
“How does an anticholinergic agent added to an inhaled short-acting beta-agonist (SABA) compare with SABA alone for emergency management of asthma in adults?.” (2017)